NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
1 hedge funds and large institutions have $2.7K invested in NexImmune, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
10.81% less ownership
Funds ownership: 10.81% → 0% (-11%)
92% less funds holding
Funds holding: 13 → 1 (-12)
99% less capital invested
Capital invested by funds: $409K → $2.7K (-$406K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$138K |
| 2 |
SPC
Slate Path Capital
New York
|
-$102K |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$43.1K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$34.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.1K |
NEXI Hedge Fund Activity: Q3 2024 in Review
1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2024, worth a combined $2.7K — down 99% from $409K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NEXI and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $138K sold.
- 1 institutional investor held NexImmune, Inc. Common Stock (NEXI) as of Q3 2024, down from 13 in Q2 2024.
- Funds reported $2.7K of NexImmune, Inc. Common Stock stock for Q3 2024, down 99% quarter-over-quarter.
- 0 funds opened new NexImmune, Inc. Common Stock positions in Q3 2024 and 12 closed out, a net change of -12 holders.
- The largest NexImmune, Inc. Common Stock seller in Q3 2024 was Sabby Management, an estimated $138K sold.
Based on aggregated 13F filings for Q3 2024.